Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: CALGB C140503: A Phase III Randomized Trial of Lobectomy versus sublobar Resection for Small (< 2 cm) peripheral non-small cell lung cancer

 


CALGB C140503: A Phase III Randomized Trial of Lobectomy versus sublobar Resection for Small (< 2 cm) peripheral non-small cell lung cancer


Trial Focus

Lung Cancer

Objective

         Clinical trial of a sublobar resection (smaller segment of the lung), which is investigational, compared to a lobectomy (entire lobe of the lung) which is SOC.

IRB Protocol #

08-0147

Trial Status

OPEN

Principle Investigator

JOHN MITCHELL

Sponsor

CALGB

Contact

NIKKI AYODEJI at (720)848-0701 or NIKKI.AYODEJI@UCDENVER.EDU

Location

University of Colorado Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period to determine eligibility. A treatment period (s) that can last for the duration of surgery. A follow up period will consist of a visit to the study doctor's office for up to seven years. // Eligibility criteria include but are not limited to 18 years or older with non-small cell lung cancer.Eligibility criteria include but are not limited to 18 years or older with non-small cell lung cancer.